These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26208847)

  • 1. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum.
    Takahashi S; Kohashi K; Yamamoto H; Hirahashi M; Kumagai R; Takizawa N; Nakamura K; Maehara Y; Tanaka M; Takayanagi R; Oda Y
    Hum Pathol; 2015 Sep; 46(9):1257-66. PubMed ID: 26208847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
    Jang TJ
    Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
    Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.
    Rüschoff J; Dietmaier W; Lüttges J; Seitz G; Bocker T; Zirngibl H; Schlegel J; Schackert HK; Jauch KW; Hofstaedter F
    Am J Pathol; 1997 May; 150(5):1815-25. PubMed ID: 9137104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
    J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
    Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
    Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
    Pyo JS; Sohn JH; Kang G
    Hum Pathol; 2016 Jul; 53():91-6. PubMed ID: 27001432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary carcinoma of the large intestine: a population based analysis.
    Thirunavukarasu P; Sathaiah M; Singla S; Sukumar S; Karunamurthy A; Pragatheeshwar KD; Lee KK; Zeh H; Kane KM; Bartlett DL
    Int J Oncol; 2010 Oct; 37(4):901-7. PubMed ID: 20811712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.
    García-Solano J; Conesa-Zamora P; Trujillo-Santos J; Torres-Moreno D; Mäkinen MJ; Pérez-Guillermo M
    Hum Pathol; 2012 Jul; 43(7):1094-102. PubMed ID: 22209340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer.
    Bhangu A; Wood G; Brown G; Darzi A; Tekkis P; Goldin R
    Colorectal Dis; 2014 Apr; 16(4):O133-43. PubMed ID: 24617665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds.
    Hong M; Kim JW; Shin MK; Kim BC
    J Korean Med Sci; 2017 Oct; 32(10):1595-1602. PubMed ID: 28875602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
    Lanza G; Gafà R; Matteuzzi M; Santini A
    J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.